Light therapy in the media
THE WEST AUSTRALIAN
Interview with SYMBYX CEO reveals their technology already has regulatory approval in Australia, the UK, EU and New Zealand. Users are experiencing cognitive and motor improvements in their Parkinson's symptoms.
7 News
7NEWS reports that a new 'miracle' treatment for Parkinson's disease is about to be clinically trialled in Australia following reports of astoundingly positive results.
2GB RADIO INTERVIEW
Dr Ginni Mansberg of Radio 2GB Sydney speaks to SYMBYX CEO Wayne Markman, about a laser treatment that can be used on the gut, to treat Parkinson's disease.
THE WEEKEND AUSTRALIAN
"Let there be light".
Margaret Jarrett was diagnosed with Parkinson's disease 8 years ago. Hear about how SYMBYX light therapy helped her.
9 NEWS
"New hope for Parkinson's disease sufferers".
Ms Chen Ong shares her story of how she started playing the piano again after applying the PDCare Laser.
PARKINSON'S NSW
Australian medical technology company SYMBYX has completed its first human trial of the use of laser light therapy to reduce the symptoms of Parkinson’s by targeting the gut-brain axis.
PRESS RELEASES
EXPLORE OUR TRIALS
May 10, 2023
SYMBYX Biome, an Australian med-tech business, today announced encouraging results from a Sydney Adventist Hospital (commonly known as the San) trial. These results are the six month follow- up results from a triple-blinded, randomised controlled trial run by the San which investigated the efficacy of the SYMBYX Neuro, a new red/infrared light therapy helmet device on People with Parkinson’s (PWP).
March 17, 2023
SYMBYX, an Australian medtech company developing light therapies for intractable disease conditions, today announced the results of a Sydney Adventist Hospital (commonly known as the San) triple-blinded, randomised controlled trial investigating the effects of a new red/infrared light therapy helmet on patients living with Parkinson’s Disease.
April 22, 2022
SYMBYX, the Australian medical laser company with the world’s first non-pharmaceutical therapy for Parkinson’s, today announced the start of a ground-breaking clinical trial of laser light therapy (photobiomodulation or PBM) on young adults suffering from IBD.
March, 2022
SYMBYX will begin a major clinical trial in Canada using its proprietary treatment system. It's the first Canadian study to examine efficacy of treatment on Parkinson’s symptoms
August, 2021
SYMBYX, an Australian med-tech company developing laser light therapies to reduce Parkinson’s symptoms, said it welcomed the publication of key findings from its Adelaide clinical trial in the leading BMC Neurology Journal.
Light Therapy in the Media
READ ARTICLES NOW
The West Australian
Symbyx CEO Wayne Markman says its technology is delivering cognitive and motor improvements...
Read article2GB Radio Interview
A new potential treatment for Parkinson's was showing some very promising results...
LISTEN NOWThe Weekend Australian
Parkinson's: Let there be light. Margaret Jarrett was diagnosed with Parkinson's disease 8 years ago ...
Read Article9 News
9 News highlights how patients with Parkinson’s
are able to treat it at home using the SYMBYX PDCare Laser.
Parkinson's NSW
Australian medical technology company SYMBYX has completed its first human trial of the use of laser light therapy to reduce the symptoms of Parkinson’s by targeting the gut-brain axis.
Read ArticleGoop
Goop highlights how light therapy is useful towards those with neurodegenerative conditions and touches on clinical trials around the world.
Read ArticleSurfers Health
Surfers Health displays how Parkinson’s treatment is changing from physical therapy and medicine to light therapy through clinical trials.
Read Article